Cargando…
Different mutations at position 562 of the hepatitis E virus capsid proteins exhibit differential effects on viral neutralizing activity
The hepatitis E virus (HEV) capsid protein pORF2 comprises three potential N-linked glycosylation sites. One site, N562, is located at the cell attachment and neutralizing antigenic regions. The present study performed detailed analyses of the effects of specific amino acid substitutions at position...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739852/ https://www.ncbi.nlm.nih.gov/pubmed/33335573 http://dx.doi.org/10.3892/etm.2020.9542 |
_version_ | 1783623414397796352 |
---|---|
author | Xu, Mingjie Sun, Lizhi Wang, Yan Gao, Shuchun Yang, Weihua Li, Meng |
author_facet | Xu, Mingjie Sun, Lizhi Wang, Yan Gao, Shuchun Yang, Weihua Li, Meng |
author_sort | Xu, Mingjie |
collection | PubMed |
description | The hepatitis E virus (HEV) capsid protein pORF2 comprises three potential N-linked glycosylation sites. One site, N562, is located at the cell attachment and neutralizing antigenic regions. The present study performed detailed analyses of the effects of specific amino acid substitutions at position 562 in the homodimerization, glycosylation, antigenicity, immunogenicity and neutralization activities of HEV pORF2. Recombinant HEV pORF2 glycoprotein E1 (amino acids 439-617) and three mutant variants (N562L, N562C and N562K) were expressed in Pichia pastoris (P. pastoris) and SDS-PAGE, Western blot analysis, tunicamycin assay, double-antibody sandwich ELISA and in vitro PCR-based neutralization assay were performed to characterize the different constructs. All proteins were indicated to be secreted by P. pastoris and formed homodimers. Tunicamycin assay revealed the glycosylated status of the wild-type protein, but the mutants were indicated to be non-glycosylated. All proteins were immunoreactive with a neutralizing monoclonal antibody but were not recognized by the antibody after denaturation into monomers. An in vitro PCR-based neutralization assay using mouse antibodies indicated efficient neutralization against N562L, whereas antibodies against N562C and N562K were revealed to be non-neutralizing. Collectively, the present study indicated that specific amino acid substitutions at position 562 serve crucial roles in the activity of the HEV neutralizing epitope. |
format | Online Article Text |
id | pubmed-7739852 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-77398522020-12-16 Different mutations at position 562 of the hepatitis E virus capsid proteins exhibit differential effects on viral neutralizing activity Xu, Mingjie Sun, Lizhi Wang, Yan Gao, Shuchun Yang, Weihua Li, Meng Exp Ther Med Articles The hepatitis E virus (HEV) capsid protein pORF2 comprises three potential N-linked glycosylation sites. One site, N562, is located at the cell attachment and neutralizing antigenic regions. The present study performed detailed analyses of the effects of specific amino acid substitutions at position 562 in the homodimerization, glycosylation, antigenicity, immunogenicity and neutralization activities of HEV pORF2. Recombinant HEV pORF2 glycoprotein E1 (amino acids 439-617) and three mutant variants (N562L, N562C and N562K) were expressed in Pichia pastoris (P. pastoris) and SDS-PAGE, Western blot analysis, tunicamycin assay, double-antibody sandwich ELISA and in vitro PCR-based neutralization assay were performed to characterize the different constructs. All proteins were indicated to be secreted by P. pastoris and formed homodimers. Tunicamycin assay revealed the glycosylated status of the wild-type protein, but the mutants were indicated to be non-glycosylated. All proteins were immunoreactive with a neutralizing monoclonal antibody but were not recognized by the antibody after denaturation into monomers. An in vitro PCR-based neutralization assay using mouse antibodies indicated efficient neutralization against N562L, whereas antibodies against N562C and N562K were revealed to be non-neutralizing. Collectively, the present study indicated that specific amino acid substitutions at position 562 serve crucial roles in the activity of the HEV neutralizing epitope. D.A. Spandidos 2021-02 2020-11-27 /pmc/articles/PMC7739852/ /pubmed/33335573 http://dx.doi.org/10.3892/etm.2020.9542 Text en Copyright: © Xu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Xu, Mingjie Sun, Lizhi Wang, Yan Gao, Shuchun Yang, Weihua Li, Meng Different mutations at position 562 of the hepatitis E virus capsid proteins exhibit differential effects on viral neutralizing activity |
title | Different mutations at position 562 of the hepatitis E virus capsid proteins exhibit differential effects on viral neutralizing activity |
title_full | Different mutations at position 562 of the hepatitis E virus capsid proteins exhibit differential effects on viral neutralizing activity |
title_fullStr | Different mutations at position 562 of the hepatitis E virus capsid proteins exhibit differential effects on viral neutralizing activity |
title_full_unstemmed | Different mutations at position 562 of the hepatitis E virus capsid proteins exhibit differential effects on viral neutralizing activity |
title_short | Different mutations at position 562 of the hepatitis E virus capsid proteins exhibit differential effects on viral neutralizing activity |
title_sort | different mutations at position 562 of the hepatitis e virus capsid proteins exhibit differential effects on viral neutralizing activity |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739852/ https://www.ncbi.nlm.nih.gov/pubmed/33335573 http://dx.doi.org/10.3892/etm.2020.9542 |
work_keys_str_mv | AT xumingjie differentmutationsatposition562ofthehepatitiseviruscapsidproteinsexhibitdifferentialeffectsonviralneutralizingactivity AT sunlizhi differentmutationsatposition562ofthehepatitiseviruscapsidproteinsexhibitdifferentialeffectsonviralneutralizingactivity AT wangyan differentmutationsatposition562ofthehepatitiseviruscapsidproteinsexhibitdifferentialeffectsonviralneutralizingactivity AT gaoshuchun differentmutationsatposition562ofthehepatitiseviruscapsidproteinsexhibitdifferentialeffectsonviralneutralizingactivity AT yangweihua differentmutationsatposition562ofthehepatitiseviruscapsidproteinsexhibitdifferentialeffectsonviralneutralizingactivity AT limeng differentmutationsatposition562ofthehepatitiseviruscapsidproteinsexhibitdifferentialeffectsonviralneutralizingactivity |